[ad_1]
Huntington’s disease is a hereditary condition that leads to the progressive degeneration of nerve cells (neurons) in specific areas of the brain. This mainly affects areas that control voluntary movements and other major brain functions. Over time, HD experience motor, individuals with emotional, cognitive and practical challenges. Doctors say that it has been successfully treated for the first time through experimental gene therapy, average 75% decrease in the progression of the disease with patients.
For example, involuntary movements can occur in fingers, legs, face, or torso, which are characterized by Korea. These movements often become strong when a person feels worried or distracted. As the progression of Huntington’s disease, these movements become more severe and noticeable.
For some individuals, Korea, involuntary, due to jerky movements, can make it difficult to walk, increase the risk of falling. However, not everyone develops Korea with Huntington Disease (HD). Some may experience rigor, which is characterized by hardness and low movement, a condition known as Ayxia.
In some cases, people initially show choria but gradually become rigid as the progression of the disease. Additionally, some can develop some diastonia, where they have unusual, fixed body postures. Akinesia and dystonia can sometimes overlap or optional. Other movement issues may include shocks, inadvertent muscle shocks and irregular eye movements, which may appear early in the disease.
Physical symptoms in Huntington Disease
Physical symptoms can include slases and difficulties with swallowing, eating and walking. Due to these challenges, many individuals with HD may experience weight loss due to feeding, knee and frequent chest infections. Other common symptoms include insomnia (difficulty in sleeping), low energy, fatigue and seizures. As the disease increases, the person can be limited to a bed or wheelchair.
‘75% clinical progress slow’
The results of the testing involving 29 patients were declared in a statement by the company Unique, although full conclusions have not yet been published by independent experts to review. According to the data, three years after undergoing surgery, patients showed a average decrease in the progression of the disease based on a joint measure of cognitive abilities, motor skills and daily functioning. BBC Report.
Pro. According to Sarah Tabariji, this means that it will usually take about four years for the decline in a year, potentially patients will be offered high quality lives over several and years. The report states that the treatment of success includes a form of gene therapy, distributed through a delicate brain surgery between 12 and 18 hours.
“We never expect to slow down 75% of clinical progress in our wild dreams,” BBC Quoted Tabariji.
The Chief Medical Officer of Unicure, Dr. Walid Abi-Sab said that he was “incredibly excited” about the results for families and mentioned that treatment had the ability to original “Huntington’s disease”.
[ad_2]
